The auditing agency questions the lack of business rationality in multiple Business activities, while ST Chuntian warns of "increased risk" and hits the lower limit.

①ST Chuntian has multiple Business operations questioned by the auditing institution for lack of commercial rationale, and the company's 2024 annual report may be issued with an inability to express an opinion or a negative opinion. ② The auditing institution has preliminarily determined that ST Chuntian's adjusted or deducted revenue will be less than 0.3 billion yuan, triggering a financial risk warning for being (Delisted). ③ ST Chuntian stated that it will cooperate with the relevant auditing work and provide sufficient audit evidence to eliminate the auditors' concerns.

cls.cnApr 17 02:03 ET

The price increase of Vitamins helped Xiamen Kingdomway Group achieve a 24% increase in net profit last year, while the gross profit margin of the core product coenzyme Q10 continued to be under pressure.|Interpretations

① Xiamen Kingdomway Group had a poor start but ended strong last year, meeting Brokerage expectations; ② The price increase of VA was the main reason for the performance growth, but prices have dropped to low levels this year; ③ Core product coenzyme Q10 has seen strong production and sales but the gross profit continues to decline.

cls.cnApr 9 09:36 ET

The "breeding heat" has led to an increase in piglet prices, listed pig companies are increasing piglet sales, and pasture companies are emerging丨Industry dynamics.

① Recently, the price of piglets has risen for three consecutive weeks, leading listed pig enterprises to increase piglet sales; ② Currently, breeding sows are being concentrated in listed pig enterprises and group pig enterprises, while smallholders mainly focus on piglet fattening and secondary fattening, and free-range farming companies are on the rise.

cls.cnMar 31 07:48 ET

Beef companies are generally under pressure, with Bright Meat Industry's net income excluding non-recurring items falling over 40% year-on-year丨Interpretations

① Guangming Meat Industry's revenue and net income have declined for two consecutive years; ② In the fourth quarter of 2024, the company's main revenue is 5.603 billion yuan, with a net income of -0.165 billion yuan for the quarter.

cls.cnMar 28 23:43 ET

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 2 21:09 ET

The recovery of pork prices has driven a significant increase in the performance of the "Noodle King." Chen Ke Ming Food Manufacturing expects to turn profits in 2024 with net income returning to the positive | Interpretations

① Chen Ke Ming Food Manufacturing expects to achieve a Net income of 0.12 billion yuan to 0.18 billion yuan in 2024, turning losses into profits year-on-year; ② In 2024, the price of live pigs is expected to rebound, and Chen Ke Ming Food Manufacturing is likely to return to profitability. However, due to capacity constraints, the revenue from the live pig Sector may have difficulty keeping pace with the soaring pig prices.

cls.cnJan 22 10:59 ET